AvantGuard

AvantGuard is a venture backed, Cornell University spin-off, IndieBio/SOSV alum with grant funding from the NIH and NSF, among others, run by an experienced entrepreneur. They have a strategic advantage in the >$100 billion skincare/dermatology market as well as an early-revenue, capital-efficient, low-risk model to bring products to market.